ConductScience.org, home

Paper42957747PubMed

ASIC1a promotes liver fibrosis by inhibiting METTL3 SUMOylation.

Li ZH and 25 others. Acta Pharmacol Sin, 2026.

Cite this record

ConductScience Library. ASIC1a promotes liver fibrosis by inhibiting METTL3 SUMOylation. Papers, record 42957747. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42957747

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
ASIC1a promotes liver fibrosis by inhibiting METTL3 SUMOylation.
Journal
Acta Pharmacol Sin
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-30

Source PubMed

Authors26

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li ZHZi-Hao
2Li MXMeng-Xue
3Song YHYong-Hu
4Ren RHRuo-Han
5Zhang TTTing-Ting
6Huang WJWan-Jing
7Harry AMAsena Musonye
8Shah KAKiramat Ali
9Wang YYYu-Yan
10Liu ZJZi-Jun
11Chen HYHao-Yang
12Qian SHShis-Hun
13Xu ZZhou
14Zhang JRJing-Rong
15Tay LJLynn Jia
16Zhang ZWZi-Wen
17Liu JJun
18Hu CMCheng-Mu
19Yang FRFu-Rong
20Hou HHui

Source PubMed

See all 26 authorsDownload CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136990226Global burden of liver disease: 2023 update.J Hepatol2023https://conductscience.org/library/papers/36990226PubMed
239036382Cancer incidence and mortality in China, 2022.J Natl Cancer Cent2024https://conductscience.org/library/papers/39036382PubMed
333128017Molecular and cellular mechanisms of liver fibrosis and its regression.Nat Rev Gastroenterol Hepatol2021https://conductscience.org/library/papers/33128017PubMed
434621747Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy.Front Cell Dev Biol2021https://conductscience.org/library/papers/34621747PubMed
537400694Hepatic inflammatory responses in liver fibrosis.Nat Rev Gastroenterol Hepatol2023https://conductscience.org/library/papers/37400694PubMed
628487545Mechanisms of hepatic stellate cell activation.Nat Rev Gastroenterol Hepatol2017https://conductscience.org/library/papers/28487545PubMed
738987597Glutamate acts on acid-sensing ion channels to worsen ischaemic brain injury.Nature2024https://conductscience.org/library/papers/38987597PubMed
829513651Gating mechanisms of acid-sensing ion channels.Nature2018https://conductscience.org/library/papers/29513651PubMed
931903118ASIC1a induces synovial inflammation via the Ca2+/NFATc3/ RANTES pathway.Theranostics2020https://conductscience.org/library/papers/31903118PubMed
1037820466Kaempferol attenuates carbon tetrachloride (CCl4)-induced hepatic fibrosis by promoting ASIC1a degradation and suppression of the ASIC1a-mediated ERS.Phytomedicine2023https://conductscience.org/library/papers/37820466PubMed
1132949431ASIC1a regulates miR-350/SPRY2 by N6 -methyladenosine to promote liver fibrosis.FASEB J2020https://conductscience.org/library/papers/32949431PubMed
1230291941ASIC1a promotes high glucose and PDGF-induced hepatic stellate cell activation by inducing autophagy through CaMKKβ/ERK signaling pathway.Toxicol Lett2019https://conductscience.org/library/papers/30291941PubMed
1330938088PI3-kinase/Akt pathway-regulated membrane transportation of acid-sensing ion channel 1a/Calcium ion influx/endoplasmic reticulum stress activation on PDGF-induced HSC Activation.J Cell Mol Med2019https://conductscience.org/library/papers/30938088PubMed
1435923112The m6A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis.Mol Ther2022https://conductscience.org/library/papers/35923112PubMed
1532203053m6A-induced lncRNA MALAT1 aggravates renal fibrogenesis in obstructive nephropathy through the miR-145/FAK pathway.Aging (Albany NY)2020https://conductscience.org/library/papers/32203053PubMed
1634111558m6A modification regulates lung fibroblast-to-myofibroblast transition through modulating KCNH6 mRNA translation.Mol Ther2021https://conductscience.org/library/papers/34111558PubMed
1731705931SUMOylation homeostasis in tumorigenesis.Cancer Lett2020https://conductscience.org/library/papers/31705931PubMed
1832483411SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma.Theranostics2020https://conductscience.org/library/papers/32483411PubMed
1929506078SUMOylation of the m6A-RNA methyltransferase METTL3 modulates its function.Nucleic Acids Res2018https://conductscience.org/library/papers/29506078PubMed
2028521030HDOCK: a web server for protein-protein and protein-DNA/RNA docking based on a hybrid strategy.Nucleic Acids Res2017https://conductscience.org/library/papers/28521030PubMed

See all 43 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42957747

GET https://conductscience.org/api/papers/v1/42957747/authors?page=2